SCHEMBL26074120

SCHEMBL26074120

COc1ccc(-c2ccc(-c3cc(C)c4cc(F)ccc4n3)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 2/20 0.64
▸ DHODH Q02127 4/20 0.53
▸ ACP1 P24666 4/20 0.53
▸ KDM4E B2RXH2 4/20 0.51
▸ LMNA P02545 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ ACACA Q13085 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ AURKA O14965 1/20 0.49
▸ AURKB Q96GD4 1/20 0.49
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ SQOR Q9Y6N5 1/20 0.46
▸ POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26074081 0.88 DHODH (0.65) PLA2G2ADHODHACP1KDM4EALDH1A1
SCHEMBL26075230 0.87 PLA2G2A (0.54) PLA2G2ADHODHACP1KDM4ELMNA
SCHEMBL26075552 0.85 DHODH (0.51) PLA2G2ADHODHACP1MAPTALDH1A1
SCHEMBL26649544 0.84 PLA2G2A (0.65) PLA2G2ADHODHACP1KDM4ELMNA
SCHEMBL23590067 0.83 PLA2G2A (0.82) PLA2G2ADHODHKDM4ELMNAMAPT
SCHEMBL26075533 0.83 PLA2G2A (0.63) PLA2G2ADHODHACP1KDM4ELMNA
SCHEMBL29617671 0.83 PLA2G2A (0.82) PLA2G2ADHODHKDM4ELMNAMAPT
SCHEMBL26074069 0.83 DHODH (0.49) PLA2G2ADHODHACP1ALDH1A1MEN1
SCHEMBL14700162 0.82 DHODH (0.58) PLA2G2ADHODHACP1KDM4ELMNA
SCHEMBL875697 0.81 KDM4E (0.58) PLA2G2AACP1KDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD PLA2G2A 1679/4885DHODH 1/4885ACP1 2245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback